drugset / Trial / NCT04225208
Pharmacokinetic and Mass Balance Study of Orally Administered [14C]-AZD4205 in Healthy Adult Male Volunteers
NaSingle-groupOpen-labelOther
Summary
This is a phase I, open label, healthy volunteers, ADME study with single oral administration of \[14C\]-AZD4205.
Timeline
- Start
- 2020-01-06
- Primary completion
- 2020-03-02
- Completion
- 2020-03-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Golidocitinib | Small molecule | 50 mg | Oral |
Indications
No indication recorded.